Publication | Open Access
Compound LM9, a novel MyD88 inhibitor, efficiently mitigates inflammatory responses and fibrosis in obesity-induced cardiomyopathy
28
Citations
18
References
2020
Year
InflammationMetabolic SyndromeCardiomyopathyFibrosisCardiovascular DiseaseMedicinePhysiologyImmunologyObesity-induced CardiomyopathyNovel Myd88 InhibitorPharmacologyCompound Lm9Health Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1